Eva Hoke und Meeting Person-Info 

( Ich bin Eva Hoke)
(1 - 4 von 4
)

Annual Meeting of the American Society of Hematology Highlights...

www.finanznachrichten.de
Title: "Feasibility of Administering Oblimersen (G3139; Genasense) with Imatinib Mesylate in Patients with Imatinib Resistant Chronic Myeloid Leukemia (CML) - Cancer and Leukemia Group B Study " Authors: Meir Wetzler, Daohai Yu, Olatoyosi Odenike, Eric J. Feldman, David D. Hurd, Eva Hoke, Vera Hars, Richard A. Larson
+1